Retrospective Study in Patients Receiving Two or More OZURDEX® Injections for Retinal Vein Occlusion (RVO)
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
This is a retrospective data collection study to evaluate the efficacy, safety, and
re-injection interval of OZURDEX® in the treatment of macular edema due to RVO. Following
informed consent, there were no patient study visits. All data was collected via chart
review.